StocksW › WWR

Westwater Resources, Inc. (WWR) — Earnings Call X-Ray

Our AI read all 25 of WWR's earnings calls (2017–2024) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q4 2023 · sign up to see
Previous Call Grade
C+
Q2 2023
Expected Move
🔒
next 45 days · members
Calls Analyzed
25
2017–2024
Avg Candor
5.8/9
evasion 3.2/9
High CandorCritic AmmunitionVolume Step-UpEarly Product, Fast GrowthUnderused Fixed CostsDemand AcceleratingCapex IncreasingReads Rehearsed

Call-by-call analysis

🔒 Q4 2023 earnings call 2024-03-20 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q4 2023 call grade is ready
The full 37-point AI read of WWR's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C+ Q2 2023 earnings call 2023-08-15

Management gave no formal guidance against accelerating demand. The delivery was unusually candid, rich in specifics.

Demand: acceleratingCapex: increasing 2 analysts · 8 questions
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubts✓ Volume step-up ahead✓ Early product, fast growth⚑ Reads rehearsed
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q1 2023 earnings call 2023-05-11

Management held guidance steady against accelerating demand. The delivery was rich in specifics.

Guidance: maintainedDemand: acceleratingBacklog: growingCapex: increasing 2 analysts · 4 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead⚑ Reads rehearsedDirection beats results
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 7/9
Uncertainty 5/9
Promotion 6/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q4 2022 earnings call 2023-03-07 move ±13.3%

Management gave no formal guidance against accelerating demand. The delivery was rich in specifics.

Demand: acceleratingHeadcount: growingCapex: increasing 2 analysts · 16 questions
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubts✓ Volume step-up ahead✓ Early product, fast growth⚑ Reads rehearsed
Candor 6/9
Specificity 8/9
Evasion 4/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
YES Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q3 2022 earnings call 2022-11-10 move ±13.7%

Management held guidance steady against accelerating demand. The delivery was rich in specifics, frequently evasive.

Guidance: maintainedDemand: acceleratingPricing: raisingHeadcount: growingCapex: increasing 5 analysts · 16 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead✓ Early product, fast growth⚑ Reads rehearsedDirection beats results
Candor 5/9
Specificity 7/9
Evasion 6/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q2 2022 earnings call 2022-08-11 move ±18.3%

Management gave no formal guidance. The delivery was rich in specifics.

Headcount: growingCapex: increasing 3 analysts · 13 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead⚑ Reads rehearsedDirection beats results
Candor 6/9
Specificity 7/9
Evasion 5/9
Confidence 7/9
Uncertainty 4/9
Promotion 4/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q1 2021 earnings call 2022-05-11 move ±12.6%

Management gave no formal guidance. The delivery was rich in specifics.

Headcount: growingCapex: increasing 2 analysts · 8 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead⚑ Reads rehearsedDirection beats results
Candor 6/9
Specificity 7/9
Evasion 4/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q4 2021 earnings call 2022-02-14 move ±15.1%

Management gave no formal guidance against accelerating demand.

Demand: acceleratingCapex: increasing 3 analysts · 7 questions
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubtsDirection beats results
Candor 6/9
Specificity 6/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q3 2021 2021-11-11 C+ maintainedacceleratingunclear 6/9 2/9
Q2 2021 2021-08-12 D noneunclearunclear 6/9 4/9
Q1 2021 2021-05-13 C maintainedacceleratingunclear 6/9 2/9
Q4 2020 2021-02-16 F noneacceleratingunclear 6/9 5/9
Q3 2020 2020-11-12 D noneunclearunclear 6/9 3/9
Q2 2020 2020-08-08 D noneunclearunclear 5/9 3/9
Q1 2020 2020-05-14 D noneacceleratingunclear 6/9 1/9
Q4 2019 2020-02-18 D noneacceleratingunclear 6/9 3/9
Q3 2019 2019-11-07 D noneunclearunclear 6/9 2/9
Q2 2019 2019-08-08 F noneunclearcontracting 6/9 4/9
Q1 2019 2019-05-08 D noneunclearunclear 6/9 2/9
Q4 2018 2019-02-19 F noneunclearcontracting 5/9 4/9
Q3 2018 2018-11-10 D noneunclearcontracting 7/9 3/9
Q2 2018 2018-08-09 F maintainedacceleratingunclear 6/9 3/9
Q1 2018 2018-05-14 F noneacceleratingunclear 5/9 5/9
Q4 2017 2018-03-02 D noneacceleratingunclear 6/9 2/9
Q3 2017 2017-11-13 F noneacceleratingunclear 5/9 3/9

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AA · Alcoa CorporationAAALF · Aareal Bank AGAABKF · Aareal Bank AGAAGIY · AIA Group LimitedAAL · American Airlines Group AAPL · Apple Inc.

WWLNF   All “W” companies    WWW

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.